|
GLUD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93032999999954E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.95959999999396E-05 |
| Normal-vs-Stage2 |
4.079300E-03 |
| Normal-vs-Stage3 |
7.395700E-04 |
| Normal-vs-Stage4 |
3.92930021853033E-10 |
| Stage1-vs-Stage2 |
8.120800E-01 |
| Stage1-vs-Stage3 |
8.154400E-01 |
| Stage1-vs-Stage4 |
6.26919999999753E-05 |
| Stage2-vs-Stage3 |
7.196400E-01 |
| Stage2-vs-Stage4 |
1.168300E-02 |
| Stage3-vs-Stage4 |
1.891510E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41290000000594E-05 |
| Normal-vs-AfricanAmerican |
1.5364499999948E-05 |
| Normal-vs-Asian |
6.703500E-03 |
| Caucasian-vs-AfricanAmerican |
7.341000E-01 |
| Caucasian-vs-Asian |
6.194600E-01 |
| AfricanAmerican-vs-Asian |
6.489000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47870000022365E-07 |
| Normal-vs-Female |
7.096700E-03 |
| Male-vs-Female |
2.822000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.77199999959765E-07 |
| Normal-vs-Extreme_Weight |
3.01239999944691E-07 |
| Normal-vs-Obese |
8.25250000000555E-05 |
| Normal-vs-Extreme_Obese |
3.833800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.492600E-01 |
| Normal_Weight-vs-Obese |
1.249010E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.184400E-01 |
| Extreme_Weight-vs-Obese |
1.632400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.839400E-01 |
| Obese-vs-Extreme_Obese |
7.051400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.05599999999928E-06 |
| Normal-vs-Age(41-60Yrs) |
4.27240000000495E-05 |
| Normal-vs-Age(61-80Yrs) |
1.221630E-04 |
| Normal-vs-Age(81-100Yrs) |
4.32069999778406E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.054500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.867820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.910810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.845600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.436900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.797100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.784500E-04 |
| Normal-VS-Type2 PRCC |
3.86430000000049E-05 |
| Normal-VS-KIRP CIMP |
1.84860005081333E-09 |
| Normal-VS-Unclassified PRCC |
7.101900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.267200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.49839999999702E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.245000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.006400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.167200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.684900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.37089999999674E-05 |
| Normal-vs-N1 |
1.30539999998458E-06 |
| Normal-vs-N2 |
7.385700E-04 |
| N0-vs-N1 |
3.048200E-01 |
| N0-vs-N2 |
1.847190E-01 |
| N1-vs-N2 |
2.607400E-01 |
|
|
